Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies

AbstractObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.DesignSystematic review and meta-analysis of prospective cohort studies.Data sourcesPubMed, Scopus,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ (Online) Ročník 375; s. n2213
Hlavní autoři: Naghshi, Sina, Aune, Dagfinn, Beyene, Joseph, Mobarak, Sara, Asadi, Masoomeh, Sadeghi, Omid
Médium: Journal Article
Jazyk:angličtina
Vydáno: England British Medical Journal Publishing Group 13.10.2021
BMJ Publishing Group LTD
BMJ Publishing Group Ltd
Témata:
ISSN:1756-1833, 0959-8138, 1756-1833
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract AbstractObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.DesignSystematic review and meta-analysis of prospective cohort studies.Data sourcesPubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021.Study selectionProspective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer.Data synthesisSummary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality.Results41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14).ConclusionsThe findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only.Systematic review registrationPROSPERO CRD42021229487.
AbstractList AbstractObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.DesignSystematic review and meta-analysis of prospective cohort studies.Data sourcesPubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021.Study selectionProspective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer.Data synthesisSummary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality.Results41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14).ConclusionsThe findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only.Systematic review registrationPROSPERO CRD42021229487.
To examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.OBJECTIVETo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.Systematic review and meta-analysis of prospective cohort studies.DESIGNSystematic review and meta-analysis of prospective cohort studies.PubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021.DATA SOURCESPubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021.Prospective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer.STUDY SELECTIONProspective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer.Summary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality.DATA SYNTHESISSummary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality.41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14).RESULTS41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14).The findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only.CONCLUSIONSThe findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only.PROSPERO CRD42021229487.SYSTEMATIC REVIEW REGISTRATIONPROSPERO CRD42021229487.
ObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.DesignSystematic review and meta-analysis of prospective cohort studies.Data sourcesPubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021.Study selectionProspective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer.Data synthesisSummary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality.Results41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14).ConclusionsThe findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only.Systematic review registrationPROSPERO CRD42021229487.
To examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer. Systematic review and meta-analysis of prospective cohort studies. PubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021. Prospective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer. Summary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality. 41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I =77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I =48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I =5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I =3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I =76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I =30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I =8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I =37.1%, n=14). The findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only. PROSPERO CRD42021229487.
Author Mobarak, Sara
Asadi, Masoomeh
Beyene, Joseph
Aune, Dagfinn
Naghshi, Sina
Sadeghi, Omid
Author_xml – sequence: 1
  givenname: Sina
  surname: Naghshi
  fullname: Naghshi, Sina
  organization: Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 2
  givenname: Dagfinn
  surname: Aune
  fullname: Aune, Dagfinn
  organization: Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
– sequence: 3
  givenname: Joseph
  surname: Beyene
  fullname: Beyene, Joseph
  organization: Chanchlani Research Centre, McMaster University, Hamilton, ON, Canada
– sequence: 4
  givenname: Sara
  surname: Mobarak
  fullname: Mobarak, Sara
  organization: Abadan University of Medical Sciences, Abadan, Iran
– sequence: 5
  givenname: Masoomeh
  surname: Asadi
  fullname: Asadi, Masoomeh
  organization: Department of Operating Room Nursing, Abadan University of Medical Sciences, Abadan, Iran
– sequence: 6
  givenname: Omid
  orcidid: 0000-0002-1029-1652
  surname: Sadeghi
  fullname: Sadeghi, Omid
  email: omidsadeghi69@yahoo.com
  organization: Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34645650$$D View this record in MEDLINE/PubMed
BookMark eNptkt9qFDEUxgep2Fp74QtIQIQKnTaZTGYyXgil_oWCN3odzmbOuNnNJNsks7Iv5vOZ3W1LrV6dQ_I7Xz5OvufFgfMOi-Ilo-eM8eZiNi7OXVUx_qQ4Yq1oSiY5P3jQHxYnMS4opRVvZdeIZ8Uhr5taNIIeFb8_GEwQNsS4BEsk4HoyM36EsMQQiR8I2NUciDXOW3RGE9Cm32HBxOUesETDFPEsl9Abv4aoJwvhbIdpcBoDGX1IYE3avCNxExOOkLJYwLXBXzuu9xHLgHHlXUQyZlclOLCbaHY2tJ9nBRLT1BuML4qnA9iIJ7f1uPjx6eP3qy_l9bfPX68ur8uZ4G0qgSGlje6YrtuhHQbRVnImczNoLnVHddf1nLMaRdu0PQhNqwr6WkuoeyYGxo-L93vd1TQbsdfoUgCrVsHkDW2UB6P-vnFmrn76tZKCcUF5Fji9FQj-ZsKY1GiiRmvBoZ-iqoSsGJVNs33r9SN04aeQV7ClOi472rUyU68eOrq3cvelGbjYAzr4GAMOSpuUl-23Bo1VjKptblTOjdrlJk-8fTRxJ_o_9s2e3R7d-_uX-wNfpNQZ
CitedBy_id crossref_primary_10_3390_ijms241814383
crossref_primary_10_1186_s43014_023_00217_1
crossref_primary_10_3390_metabo13050615
crossref_primary_10_3389_fimmu_2024_1297298
crossref_primary_10_1016_j_nut_2024_112358
crossref_primary_10_1080_10408398_2023_2251583
crossref_primary_10_1093_advances_nmac049
crossref_primary_10_1016_j_ajcnut_2024_11_029
crossref_primary_10_1007_s00394_025_03739_1
crossref_primary_10_1186_s12902_023_01412_4
crossref_primary_10_3390_antiox12050982
crossref_primary_10_1016_j_tifs_2022_08_002
crossref_primary_10_1016_j_nutres_2024_09_003
crossref_primary_10_1186_s40246_024_00591_y
crossref_primary_10_1016_j_tifs_2022_10_011
crossref_primary_10_3390_foods14091566
crossref_primary_10_1002_fsn3_4405
crossref_primary_10_1016_j_prostaglandins_2023_106704
crossref_primary_10_1016_j_heliyon_2024_e39810
crossref_primary_10_1093_nutrit_nuad054
crossref_primary_10_1016_j_ecoenv_2023_115182
crossref_primary_10_1136_bmj_n2379
crossref_primary_10_3389_fphar_2024_1437760
crossref_primary_10_1016_j_annepidem_2022_10_015
crossref_primary_10_3390_foods12163005
crossref_primary_10_1016_j_jsbmb_2025_106677
crossref_primary_10_3389_fnut_2022_970364
crossref_primary_10_3389_fnmol_2024_1398665
crossref_primary_10_1016_j_antiviral_2023_105666
crossref_primary_10_3390_nu16244325
crossref_primary_10_1002_efd2_70039
crossref_primary_10_3390_app14041372
crossref_primary_10_3390_foods14040704
crossref_primary_10_1007_s40120_023_00477_6
crossref_primary_10_1111_ijfs_16158
crossref_primary_10_3390_ani12091113
crossref_primary_10_1186_s40543_025_00486_0
crossref_primary_10_1038_s41388_024_03073_6
crossref_primary_10_3390_ijerph19031256
crossref_primary_10_2147_VHRM_S379874
crossref_primary_10_1111_1753_0407_70110
crossref_primary_10_1007_s11906_023_01243_7
crossref_primary_10_1016_j_biopha_2025_118567
crossref_primary_10_1016_j_cnd_2025_02_004
crossref_primary_10_3390_foods13172739
crossref_primary_10_3389_fphar_2022_882197
crossref_primary_10_1016_j_micres_2024_127773
crossref_primary_10_1016_j_cdnut_2024_104407
crossref_primary_10_1016_j_clnesp_2022_02_001
crossref_primary_10_3389_fnut_2023_1079407
crossref_primary_10_1007_s13668_024_00547_7
crossref_primary_10_1016_j_archger_2023_105230
crossref_primary_10_1016_j_ajcnut_2024_11_012
crossref_primary_10_1080_10408398_2023_2200840
crossref_primary_10_1186_s12986_023_00753_0
crossref_primary_10_3389_fendo_2022_968984
crossref_primary_10_3390_ijms25094909
crossref_primary_10_3390_ijms26167776
crossref_primary_10_3390_foods13081167
crossref_primary_10_1016_j_clnu_2023_09_011
crossref_primary_10_1111_eci_14382
crossref_primary_10_3390_ijms24076110
crossref_primary_10_3390_molecules27092741
crossref_primary_10_1007_s13668_025_00639_y
crossref_primary_10_3390_app12073599
crossref_primary_10_3390_nu16132071
crossref_primary_10_3389_fcvm_2021_788452
crossref_primary_10_1186_s12888_023_04715_x
crossref_primary_10_3390_nu17152419
crossref_primary_10_3389_fnut_2022_1060436
crossref_primary_10_3390_nu15204461
crossref_primary_10_3389_fnut_2024_1335538
crossref_primary_10_1161_CIRCULATIONAHA_123_065530
crossref_primary_10_3390_nu16193379
crossref_primary_10_1016_j_jspr_2022_102059
crossref_primary_10_3390_ani12233362
crossref_primary_10_1016_j_advnut_2023_09_010
crossref_primary_10_3390_foods13091405
crossref_primary_10_1097_JN9_0000000000000046
crossref_primary_10_1016_j_jlr_2023_100493
crossref_primary_10_1097_MCO_0000000000001006
crossref_primary_10_3390_molecules29040754
crossref_primary_10_1186_s13643_023_02209_1
crossref_primary_10_3390_molecules27144471
crossref_primary_10_1038_s41387_024_00262_w
crossref_primary_10_1038_s41598_024_78486_0
crossref_primary_10_1016_j_numecd_2023_02_025
crossref_primary_10_3390_nu14020239
Cites_doi 10.1016/j.clnu.2018.02.019
10.1186/1471-2288-14-70
10.1016/S0140-6736(14)60648-6
10.1093/ajcn/80.1.204
10.1016/j.nutres.2016.09.006
10.1080/17512433.2017.1333902
10.1055/s-0038-1642387
10.1177/1536867X0600600103
10.3181/00379727-200-43413
10.1161/CIRCOUTCOMES.109.896159
10.1093/ndt/gfs132
10.1093/ajcn/88.1.203
10.1016/j.atherosclerosis.2016.06.049
10.1001/jama.279.18.1477
10.1017/S0007114517003294
10.3945/an.114.006940
10.1161/CIRCULATIONAHA.115.015607
10.1161/JAHA.120.017401
10.1038/s41467-021-22370-2
10.1093/ajcn/nqz349
10.1001/archinte.165.2.193
10.3945/ajcn.110.009977
10.1136/bmj.g7647
10.1038/s41416-020-0761-6
10.1093/ajcn/69.5.890
10.1146/annurev-food-111317-095850
10.1161/CIRCRESAHA.118.314038
10.1194/jlr.R055095
10.3945/ajcn.115.127019
10.1016/j.jacl.2016.12.013
10.1158/1055-9965.EPI-18-0940
10.1002/cncr.29329
10.1016/j.clnu.2019.02.030
10.1136/bmj.l4009
10.1136/bmj.327.7414.557
10.1093/ajcn/74.4.457
10.1016/S0140-6736(10)60484-9
10.3945/ajcn.112.044040
10.1001/jamainternmed.2016.2925
10.1159/000419291
10.1136/bmj.313.7049.84
10.1016/j.fitote.2017.09.015
10.1001/jamainternmed.2013.6536
10.1016/j.clnu.2020.03.028
10.3945/ajcn.2009.26736E
10.1002/ijc.32233
10.1016/j.jacl.2018.02.010
10.1093/ajcn/78.1.65
10.1016/j.metabol.2008.11.013
10.1186/1741-7015-11-164
10.1001/jamainternmed.2016.2417
10.1038/nrcardio.2017.154
10.1093/ajcn/88.3.722
10.1016/j.amepre.2016.07.020
10.1016/j.lfs.2018.04.049
10.1002/ijc.29210
10.1161/CIRCULATIONAHA.105.572008
10.1002/ijc.31247
10.1093/aje/kwr520
10.1002/pros.24027
doi:10.1093/oxfordjournals.aje.a116237
10.1093/aje/kwh307
10.3390/nu11122974
10.1016/j.ijcard.2012.09.076
10.1038/sj.ejcn.1602408
10.1097/00001648-200007000-00013
10.1161/JAHA.115.002543
10.1186/1476-511X-13-196
10.1093/ije/30.5.1119
10.1080/10408398.2013.828678
10.1016/j.phrs.2016.09.040
10.1186/s13643-018-0915-2
10.1093/ajcn/77.2.319
10.1186/s12916-016-0730-3
10.1016/j.cct.2015.09.002
10.1001/jamacardio.2016.2259
10.1016/j.nut.2019.110610
10.1371/journal.pone.0059408
10.1093/oxfordjournals.aje.a009047
10.1158/1055-9965.EPI-12-1196-T
10.1093/jn/134.4.919
10.1093/oxfordjournals.aje.a009710
10.1016/S0002-8223(02)90346-9
10.1016/j.jacc.2020.08.073
10.1002/14651858.CD003177.pub3
10.1017/S000711451400138X
10.1097/MCO.0000000000000439
10.1017/S0007114514001925
10.1177/2047487313517576
10.3181/0711-MR-311
10.1177/1534735416656052
ContentType Journal Article
Copyright Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ
Copyright_xml – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
– notice: 2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ
DBID 9YT
ACMMV
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88I
8AF
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AN0
ASE
AZQEC
BBNVY
BENPR
BHPHI
BTHHO
CCPQU
DWQXO
FPQ
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K6X
K9.
KB0
LK8
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1136/bmj.n2213
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Science Database (Alumni Edition)
STEM Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
British Nursing Index
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
BMJ Journals
ProQuest One Community College
ProQuest Central
British Nursing Index (BNI) (1985 to Present)
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
British Nursing Index
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
British Nursing Index
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Research Library Prep
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-1833
ExternalDocumentID PMC8513503
34645650
10_1136_bmj_n2213
bmj
Genre Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Journal Article
GroupedDBID 23N
39C
4.4
40O
53G
5GY
7RV
7X7
88I
8AF
8F7
8FE
8FH
8FI
8FJ
8G5
9YT
AACGO
AANCE
AAWJN
ABIVO
ABJNI
ABPLY
ABTLG
ABUWG
ABVAJ
ACGFS
ACGOD
ACMFJ
ACMMV
ACPRK
AFKRA
AGFXO
AHMBA
AHNKE
AHQMW
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
BTHHO
C45
CCPQU
CS3
DWQXO
EBS
EJD
F5P
FYUFA
GNUQQ
GUQSH
H13
HAJ
HCIFZ
HMCUK
HZ~
JLS
JSG
JST
L7B
LK8
M2O
M2P
M7P
NAPCQ
NXWIF
O9-
OVD
PHGZT
PQQKQ
PROAC
R53
RHI
RMJ
RV8
TEORI
UKHRP
VVN
WOQ
YFH
YQY
AAYXX
ABBHK
AEUPB
AEXZC
AFFHD
AN0
CITATION
DCCCD
IAG
IBB
IMI
IPSME
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLXEF
JPM
PHGZM
PJZUB
PPXIY
PQGLB
SA0
0R~
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
ASE
FPQ
K6X
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
PUEGO
Q9U
7X8
5PM
ID FETCH-LOGICAL-b537t-a1e006c91c47f7ff5728b87fffc38c90c99d3314e5767da5c022ad4c8a4d15f13
IEDL.DBID M7P
ISICitedReferencesCount 131
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000708090000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1756-1833
0959-8138
IngestDate Tue Nov 04 02:00:40 EST 2025
Wed Oct 01 14:10:53 EDT 2025
Mon Sep 08 13:53:42 EDT 2025
Thu Apr 03 06:53:15 EDT 2025
Sat Nov 29 04:10:51 EST 2025
Tue Nov 18 22:09:21 EST 2025
Thu Apr 24 22:49:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b537t-a1e006c91c47f7ff5728b87fffc38c90c99d3314e5767da5c022ad4c8a4d15f13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-1029-1652
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8513503
PMID 34645650
PQID 2593890978
PQPubID 2043523
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8513503
proquest_miscellaneous_2582108661
proquest_journals_2593890978
pubmed_primary_34645650
crossref_citationtrail_10_1136_bmj_n2213
crossref_primary_10_1136_bmj_n2213
bmj_journals_10_1136_bmj_n2213
PublicationCentury 2000
PublicationDate 2021-10-13
PublicationDateYYYYMMDD 2021-10-13
PublicationDate_xml – month: 10
  year: 2021
  text: 2021-10-13
  day: 13
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMJ (Online)
PublicationTitleAbbrev BMJ
PublicationTitleAlternate BMJ
PublicationYear 2021
Publisher British Medical Journal Publishing Group
BMJ Publishing Group LTD
BMJ Publishing Group Ltd
Publisher_xml – name: British Medical Journal Publishing Group
– name: BMJ Publishing Group LTD
– name: BMJ Publishing Group Ltd
References Stark, Reifen, Crawford (ref11) 2016; 56
DerSimonian, Laird (ref61) 2015; 45
Marklund, Leander, Vikström (ref28) 2015; 132
Zhuang, Zhang, He (ref37) 2019; 124
Pottala, Garg, Cohen, Whooley, Harris (ref31) 2010; 3
Kumar, Contaifer, Madurantakam (ref9) 2019; 11
Laaksonen, Nyyssönen, Niskanen, Rissanen, Salonen (ref25) 2005; 165
Saini, Keum (ref86) 2018; 203
Shamseer, Moher, Clarke (ref58) 2015; 350
Aucoin, Cooley, Knee (ref6) 2017; 16
Sala-Vila, Guasch-Ferré, Hu (ref38) 2016; 5
Balakumar, Maung-U, Jagadeesh (ref2) 2016; 113
Shahidi, Ambigaipalan (ref10) 2018; 9
Huang, Stenvinkel, Qureshi (ref70) 2012; 27
Vedtofte, Jakobsen, Lauritzen (ref42) 2014; 112
Danesh, Collins, Appleby, Peto (ref60) 1998; 279
Koh, Pan, Wang (ref24) 2015; 22
Albert, Oh, Whang (ref43) 2005; 112
Abudurexiti, Zhu, Wang (ref67) 2020; 80
Serini, Calviello (ref90) 2018; 21
Greenland, Longnecker (ref68) 1992; 135
Kleber, Delgado, Lorkowski, März, von Schacky (ref49) 2016; 252
Khankari, Bradshaw, Steck (ref23) 2015; 121
Andersson, Vasan (ref1) 2018; 15
Fretts, Mozaffarian, Siscovick (ref20) 2014; 112
Hanson, Thorpe, Winstanley, Abdelhamid, Hooper (ref89) 2020; 122
Jayanama, Theou, Godin, Cahill, Rockwood (ref50) 2020; 70
Bauer, Briss, Goodman, Bowman (ref3) 2014; 384
Harris, Tintle, Imamura (ref54) 2021; 12
Higgins, Thompson, Deeks, Altman (ref65) 2003; 327
Lemaitre, King, Mozaffarian, Kuller, Tracy, Siscovick (ref80) 2003; 77
Rhee, Kim, Buring, Kurth (ref46) 2017; 52
Orsini, Bellocco, Greenland (ref69) 2006; 6
Goyens, Mensink (ref88) 2006; 60
Wei, Hou, Xi (ref55) 2018; 119
Simon, Chen, Bent (ref56) 2009; 89
de Goede, Verschuren, Boer, Verberne, Kromhout, Geleijnse (ref15) 2013; 8
Harris, Kennedy, O’Keefe, Spertus (ref52) 2013; 168
Bero, Chartres, Diong (ref59) 2018; 7
Kilander, Berglund, Boberg, Vessby, Lithell (ref76) 2001; 30
Trumbo, Schlicker, Yates, Poos (ref93) 2002; 102
Freese, Mutanen, Valsta, Salminen (ref87) 1994; 71
Mori (ref4) 2017; 123
Pietinen, Ascherio, Korhonen (ref30) 1997; 145
Watanabe, Tatsuno (ref5) 2017; 10
Zelniker, Morrow, Scirica (ref71) 2021; 10
Wang, Li, Chiuve (ref34) 2016; 176
Miura, Hughes, Ungerer, Green (ref39) 2016; 36
Dolecek (ref75) 1992; 200
Oomen, Ocké, Feskens, Kok, Kromhout (ref29) 2001; 74
Sarwar, Gao, Seshasai (ref63) 2010; 375
Epstein, Kasperzyk, Mucci (ref17) 2012; 176
Leitzmann, Stampfer, Michaud (ref79) 2004; 80
Richman, Kenfield, Chavarro (ref32) 2013; 173
Warensjö, Sundström, Vessby, Cederholm, Risérus (ref35) 2008; 88
Perez-Cornago, Huybrechts, Appleby (ref53) 2020; 146
Lelli, Antonelli Incalzi, Ferrucci, Bandinelli, Pedone (ref26) 2020; 39
Jiao, Liu, Shin (ref22) 2019; 366
Simon, Fong, Bernert, Browner (ref33) 1998; 148
Pelser, Mondul, Hollenbeck, Park (ref45) 2013; 22
Aune, Keum, Giovannucci (ref91) 2016; 14
Lemaitre, King, Sotoodehnia (ref72) 2009; 58
Dolecek, Granditis (ref16) 1991; 66
Brouwer, Katan, Zock (ref57) 2004; 134
Zhuang, Wang, Wang, Zhang, Jiao (ref36) 2019; 38
Ferlay, Soerjomataram, Dikshit (ref64) 2015; 136
Fortes, Forastiere, Farchi, Rapiti, Pastori, Perucci (ref19) 2000; 11
Abdelhamid, Brown, Brainard (ref85) 2018; 7
Del Gobbo, Imamura, Aslibekyan (ref41) 2016; 176
van Enst, Ochodo, Scholten, Hooft, Leeflang (ref66) 2014; 14
Ascherio, Rimm, Giovannucci, Spiegelman, Stampfer, Willett (ref44) 1996; 313
Mazidi, Mikhailidis, Sattar (ref82) 2020; 39
Mozaffarian (ref13) 2005; 11
Folsom, Demissie (ref74) 2004; 160
Fritsche (ref7) 2015; 6
Harris, Luo, Pottala (ref21) 2017; 11
Spector, Kim (ref8) 2015; 56
Hu, Stampfer, Manson (ref77) 1999; 69
Lindberg, Saltvedt, Sletvold, Bjerve (ref27) 2008; 88
Harris, Tintle, Etherton, Vasan (ref48) 2018; 12
Liyanage, Ong, An, Gharahkhani, Law, MacGregor (ref73) 2019; 28
Wu, Wilson, Stampfer, Willett, Giovannucci (ref78) 2018; 142
Bork, Jakobsen, Lundbye-Christensen, Tjønneland, Schmidt, Overvad (ref14) 2016; 104
Borenstein, Hedges, Higgins (ref62) 2009; 77
Pan, Chen, Chowdhury (ref81) 2012; 96
Erkkilä, Lehto, Pyörälä, Uusitupa (ref18) 2003; 78
Gopinath, Buyken, Flood, Empson, Rochtchina, Mitchell (ref40) 2011; 93
Iggman, Ärnlöv, Cederholm, Risérus (ref47) 2016; 1
Li, Guasch-Ferré, Li, Hu (ref83) 2020; 112
Guasch-Ferré, Bulló, Martínez-González (ref92) 2013; 11
Lázaro, Rueda, Cediel (ref51) 2020; 76
Simopoulos (ref84) 2008; 233
Lee, Ivester, Hester (ref12) 2014; 13
2023030804355048000_375.oct13_9.n2213.73
2023030804355048000_375.oct13_9.n2213.72
2023030804355048000_375.oct13_9.n2213.71
2023030804355048000_375.oct13_9.n2213.70
2023030804355048000_375.oct13_9.n2213.37
2023030804355048000_375.oct13_9.n2213.36
2023030804355048000_375.oct13_9.n2213.35
2023030804355048000_375.oct13_9.n2213.79
2023030804355048000_375.oct13_9.n2213.34
2023030804355048000_375.oct13_9.n2213.78
2023030804355048000_375.oct13_9.n2213.33
2023030804355048000_375.oct13_9.n2213.77
2023030804355048000_375.oct13_9.n2213.32
2023030804355048000_375.oct13_9.n2213.76
2023030804355048000_375.oct13_9.n2213.31
2023030804355048000_375.oct13_9.n2213.75
2023030804355048000_375.oct13_9.n2213.30
2023030804355048000_375.oct13_9.n2213.74
2023030804355048000_375.oct13_9.n2213.39
2023030804355048000_375.oct13_9.n2213.38
2023030804355048000_375.oct13_9.n2213.61
2023030804355048000_375.oct13_9.n2213.60
Mozaffarian (2023030804355048000_375.oct13_9.n2213.13) 2005; 11
2023030804355048000_375.oct13_9.n2213.26
2023030804355048000_375.oct13_9.n2213.25
2023030804355048000_375.oct13_9.n2213.69
2023030804355048000_375.oct13_9.n2213.24
2023030804355048000_375.oct13_9.n2213.68
2023030804355048000_375.oct13_9.n2213.23
2023030804355048000_375.oct13_9.n2213.67
2023030804355048000_375.oct13_9.n2213.22
2023030804355048000_375.oct13_9.n2213.66
2023030804355048000_375.oct13_9.n2213.21
2023030804355048000_375.oct13_9.n2213.65
2023030804355048000_375.oct13_9.n2213.20
2023030804355048000_375.oct13_9.n2213.64
2023030804355048000_375.oct13_9.n2213.63
2023030804355048000_375.oct13_9.n2213.29
2023030804355048000_375.oct13_9.n2213.28
2023030804355048000_375.oct13_9.n2213.27
2023030804355048000_375.oct13_9.n2213.2
2023030804355048000_375.oct13_9.n2213.51
2023030804355048000_375.oct13_9.n2213.1
2023030804355048000_375.oct13_9.n2213.50
2023030804355048000_375.oct13_9.n2213.93
2023030804355048000_375.oct13_9.n2213.92
2023030804355048000_375.oct13_9.n2213.91
2023030804355048000_375.oct13_9.n2213.90
2023030804355048000_375.oct13_9.n2213.15
2023030804355048000_375.oct13_9.n2213.59
2023030804355048000_375.oct13_9.n2213.9
2023030804355048000_375.oct13_9.n2213.14
2023030804355048000_375.oct13_9.n2213.58
2023030804355048000_375.oct13_9.n2213.8
2023030804355048000_375.oct13_9.n2213.57
2023030804355048000_375.oct13_9.n2213.7
2023030804355048000_375.oct13_9.n2213.12
2023030804355048000_375.oct13_9.n2213.56
2023030804355048000_375.oct13_9.n2213.6
2023030804355048000_375.oct13_9.n2213.11
2023030804355048000_375.oct13_9.n2213.55
Borenstein (2023030804355048000_375.oct13_9.n2213.62) 2009; 77
2023030804355048000_375.oct13_9.n2213.5
2023030804355048000_375.oct13_9.n2213.10
2023030804355048000_375.oct13_9.n2213.54
2023030804355048000_375.oct13_9.n2213.4
2023030804355048000_375.oct13_9.n2213.53
2023030804355048000_375.oct13_9.n2213.3
2023030804355048000_375.oct13_9.n2213.52
2023030804355048000_375.oct13_9.n2213.19
2023030804355048000_375.oct13_9.n2213.18
2023030804355048000_375.oct13_9.n2213.17
2023030804355048000_375.oct13_9.n2213.16
2023030804355048000_375.oct13_9.n2213.40
2023030804355048000_375.oct13_9.n2213.84
2023030804355048000_375.oct13_9.n2213.83
2023030804355048000_375.oct13_9.n2213.82
2023030804355048000_375.oct13_9.n2213.81
2023030804355048000_375.oct13_9.n2213.80
2023030804355048000_375.oct13_9.n2213.48
2023030804355048000_375.oct13_9.n2213.47
2023030804355048000_375.oct13_9.n2213.46
2023030804355048000_375.oct13_9.n2213.45
2023030804355048000_375.oct13_9.n2213.89
2023030804355048000_375.oct13_9.n2213.44
2023030804355048000_375.oct13_9.n2213.88
2023030804355048000_375.oct13_9.n2213.43
2023030804355048000_375.oct13_9.n2213.87
2023030804355048000_375.oct13_9.n2213.42
2023030804355048000_375.oct13_9.n2213.86
2023030804355048000_375.oct13_9.n2213.41
2023030804355048000_375.oct13_9.n2213.85
2023030804355048000_375.oct13_9.n2213.49
References_xml – volume: 76
  start-page: 2089
  year: 2020
  ident: ref51
  article-title: Circulating Omega-3 Fatty Acids and Incident Adverse Events in Patients With Acute Myocardial Infarction
  publication-title: J Am Coll Cardiol
– volume: 27
  start-page: 3615
  year: 2012
  ident: ref70
  article-title: Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients
  publication-title: Nephrol Dial Transplant
– volume: 39
  start-page: 510
  year: 2020
  ident: ref26
  article-title: Association between PUFA intake and serum concentration and mortality in older adults: A cohort study
  publication-title: Clin Nutr
– volume: 11
  start-page: 24
  year: 2005
  ident: ref13
  article-title: Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence
  publication-title: Altern Ther Health Med
– volume: 77
  start-page: 319
  year: 2003
  ident: ref80
  article-title: n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study
  publication-title: Am J Clin Nutr
– volume: 22
  start-page: 364
  year: 2015
  ident: ref24
  article-title: The association between dietary omega-3 fatty acids and cardiovascular death: the Singapore Chinese Health Study
  publication-title: Eur J Prev Cardiol
– volume: 279
  start-page: 1477
  year: 1998
  ident: ref60
  article-title: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies
  publication-title: JAMA
– volume: 14
  start-page: 70
  year: 2014
  ident: ref66
  article-title: Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study
  publication-title: BMC Med Res Methodol
– volume: 69
  start-page: 890
  year: 1999
  ident: ref77
  article-title: Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women
  publication-title: Am J Clin Nutr
– volume: 6
  start-page: 293S
  year: 2015
  ident: ref7
  article-title: The science of fatty acids and inflammation
  publication-title: Adv Nutr
– volume: 148
  start-page: 854
  year: 1998
  ident: ref33
  article-title: Serum fatty acids and the risk of fatal cancer. MRFIT Research Group. Multiple Risk Factor Intervention Trial
  publication-title: Am J Epidemiol
– volume: 8
  year: 2013
  ident: ref15
  article-title: N-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysis
  publication-title: PLoS One
– volume: 176
  start-page: 1134
  year: 2016
  ident: ref34
  article-title: Association of Specific Dietary Fats With Total and Cause-Specific Mortality
  publication-title: JAMA Intern Med
– volume: 80
  start-page: 204
  year: 2004
  ident: ref79
  article-title: Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer
  publication-title: Am J Clin Nutr
– volume: 52
  start-page: 10
  year: 2017
  ident: ref46
  article-title: Fish Consumption, Omega-3 Fatty Acids, and Risk of Cardiovascular Disease
  publication-title: Am J Prev Med
– volume: 313
  start-page: 84
  year: 1996
  ident: ref44
  article-title: Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States
  publication-title: BMJ
– volume: 38
  start-page: 848
  year: 2019
  ident: ref36
  article-title: Polyunsaturated fatty acids intake, omega-6/omega-3 ratio and mortality: Findings from two independent nationwide cohorts
  publication-title: Clin Nutr
– volume: 112
  start-page: 3232
  year: 2005
  ident: ref43
  article-title: Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease
  publication-title: Circulation
– volume: 350
  start-page: g7647
  year: 2015
  ident: ref58
  article-title: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
  publication-title: BMJ
– volume: 7
  start-page: 242
  year: 2018
  ident: ref59
  article-title: The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures
  publication-title: Syst Rev
– volume: 375
  start-page: 2215
  year: 2010
  ident: ref63
  article-title: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
  publication-title: Lancet
– volume: 96
  start-page: 1262
  year: 2012
  ident: ref81
  article-title: α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis
  publication-title: Am J Clin Nutr
– volume: 142
  start-page: 2207
  year: 2018
  ident: ref78
  article-title: A 24-year prospective study of dietary α-linolenic acid and lethal prostate cancer
  publication-title: Int J Cancer
– volume: 93
  start-page: 1073
  year: 2011
  ident: ref40
  article-title: Consumption of polyunsaturated fatty acids, fish, and nuts and risk of inflammatory disease mortality
  publication-title: Am J Clin Nutr
– volume: 28
  start-page: 1015
  year: 2019
  ident: ref73
  article-title: Mendelian Randomization Study for Genetically Predicted Polyunsaturated Fatty Acids Levels on Overall Cancer Risk and Mortality
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 12
  start-page: 718
  year: 2018
  ident: ref48
  article-title: Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study
  publication-title: J Clin Lipidol
– volume: 132
  start-page: 586
  year: 2015
  ident: ref28
  article-title: Polyunsaturated Fat Intake Estimated by Circulating Biomarkers and Risk of Cardiovascular Disease and All-Cause Mortality in a Population-Based Cohort of 60-Year-Old Men and Women
  publication-title: Circulation
– volume: 21
  start-page: 83
  year: 2018
  ident: ref90
  article-title: Long-chain omega-3 fatty acids and cancer: any cause for concern?
  publication-title: Curr Opin Clin Nutr Metab Care
– volume: 45
  start-page: 139
  year: 2015
  ident: ref61
  article-title: Meta-analysis in clinical trials revisited
  publication-title: Contemp Clin Trials
– volume: 14
  start-page: 207
  year: 2016
  ident: ref91
  article-title: Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies
  publication-title: BMC Med
– volume: 10
  start-page: 865
  year: 2017
  ident: ref5
  article-title: Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future
  publication-title: Expert Rev Clin Pharmacol
– volume: 71
  start-page: 73
  year: 1994
  ident: ref87
  article-title: Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/alpha-linolenic acid ratio on platelet aggregation
  publication-title: Thromb Haemost
– volume: 11
  start-page: 440
  year: 2000
  ident: ref19
  article-title: Diet and overall survival in a cohort of very elderly people
  publication-title: Epidemiology
– volume: 176
  start-page: 1155
  year: 2016
  ident: ref41
  article-title: ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies
  publication-title: JAMA Intern Med
– volume: 11
  year: 2019
  ident: ref9
  article-title: Dietary Bioactive Fatty Acids as Modulators of Immune Function: Implications on Human Health
  publication-title: Nutrients
– volume: 56
  start-page: 2261
  year: 2016
  ident: ref11
  article-title: Past and Present Insights on Alpha-linolenic Acid and the Omega-3 Fatty Acid Family
  publication-title: Crit Rev Food Sci Nutr
– volume: 78
  start-page: 65
  year: 2003
  ident: ref18
  article-title: n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease
  publication-title: Am J Clin Nutr
– volume: 22
  start-page: 697
  year: 2013
  ident: ref45
  article-title: Dietary fat, fatty acids, and risk of prostate cancer in the NIH-AARP diet and health study
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 168
  start-page: 53
  year: 2013
  ident: ref52
  article-title: Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction
  publication-title: Int J Cardiol
– volume: 36
  start-page: 1202
  year: 2016
  ident: ref39
  article-title: Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study
  publication-title: Nutr Res
– volume: 88
  start-page: 722
  year: 2008
  ident: ref27
  article-title: Long-chain n-3 fatty acids and mortality in elderly patients
  publication-title: Am J Clin Nutr
– volume: 203
  start-page: 255
  year: 2018
  ident: ref86
  article-title: Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review
  publication-title: Life Sci
– volume: 70
  year: 2020
  ident: ref50
  article-title: Association of fatty acid consumption with frailty and mortality among middle-aged and older adults
  publication-title: Nutrition
– volume: 136
  start-page: E359
  year: 2015
  ident: ref64
  article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
  publication-title: Int J Cancer
– volume: 11
  start-page: 164
  year: 2013
  ident: ref92
  article-title: Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial
  publication-title: BMC Med
– volume: 88
  start-page: 203
  year: 2008
  ident: ref35
  article-title: Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study
  publication-title: Am J Clin Nutr
– volume: 384
  start-page: 45
  year: 2014
  ident: ref3
  article-title: Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA
  publication-title: Lancet
– volume: 89
  start-page: 1558S
  year: 2009
  ident: ref56
  article-title: The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis
  publication-title: Am J Clin Nutr
– volume: 66
  start-page: 205
  year: 1991
  ident: ref16
  article-title: Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT)
  publication-title: World Rev Nutr Diet
– volume: 112
  start-page: 150
  year: 2020
  ident: ref83
  article-title: Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies
  publication-title: Am J Clin Nutr
– volume: 56
  start-page: 11
  year: 2015
  ident: ref8
  article-title: Discovery of essential fatty acids
  publication-title: J Lipid Res
– volume: 74
  start-page: 457
  year: 2001
  ident: ref29
  article-title: alpha-Linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study
  publication-title: Am J Clin Nutr
– volume: 58
  start-page: 534
  year: 2009
  ident: ref72
  article-title: Red blood cell membrane alpha-linolenic acid and the risk of sudden cardiac arrest
  publication-title: Metabolism
– volume: 104
  start-page: 41
  year: 2016
  ident: ref14
  article-title: Dietary intake and adipose tissue content of α-linolenic acid and risk of myocardial infarction: a Danish cohort study
  publication-title: Am J Clin Nutr
– volume: 1
  start-page: 745
  year: 2016
  ident: ref47
  article-title: Association of Adipose Tissue Fatty Acids With Cardiovascular and All-Cause Mortality in Elderly Men
  publication-title: JAMA Cardiol
– volume: 200
  start-page: 177
  year: 1992
  ident: ref75
  article-title: Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial
  publication-title: Proc Soc Exp Biol Med
– volume: 60
  start-page: 978
  year: 2006
  ident: ref88
  article-title: Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects
  publication-title: Eur J Clin Nutr
– volume: 176
  start-page: 240
  year: 2012
  ident: ref17
  article-title: Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden
  publication-title: Am J Epidemiol
– volume: 160
  start-page: 1005
  year: 2004
  ident: ref74
  article-title: Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women
  publication-title: Am J Epidemiol
– volume: 5
  year: 2016
  ident: ref38
  article-title: Dietary α-Linolenic Acid, Marine ω-3 Fatty Acids, and Mortality in a Population With High Fish Consumption: Findings From the PREvención con DIeta MEDiterránea (PREDIMED) Study
  publication-title: J Am Heart Assoc
– volume: 233
  start-page: 674
  year: 2008
  ident: ref84
  article-title: The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases
  publication-title: Exp Biol Med (Maywood)
– volume: 119
  start-page: 83
  year: 2018
  ident: ref55
  article-title: The association and dose-response relationship between dietary intake of α-linolenic acid and risk of CHD: a systematic review and meta-analysis of cohort studies
  publication-title: Br J Nutr
– volume: 124
  start-page: 757
  year: 2019
  ident: ref37
  article-title: Dietary Fats in Relation to Total and Cause-Specific Mortality in a Prospective Cohort of 521 120 Individuals With 16 Years of Follow-Up
  publication-title: Circ Res
– volume: 252
  start-page: 175
  year: 2016
  ident: ref49
  article-title: Omega-3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen Risk and Cardiovascular Health Study
  publication-title: Atherosclerosis
– volume: 6
  start-page: 40
  year: 2006
  ident: ref69
  article-title: Generalized least squares for trend estimation of summarized dose–response data
  publication-title: Stata J
– volume: 7
  year: 2018
  ident: ref85
  article-title: Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
  publication-title: Cochrane Database Syst Rev
– volume: 112
  start-page: 735
  year: 2014
  ident: ref42
  article-title: Association between the intake of α-linolenic acid and the risk of CHD
  publication-title: Br J Nutr
– volume: 77
  start-page: 85
  year: 2009
  ident: ref62
  article-title: Fixed-effect versus random-effects models
  publication-title: Introduction to Meta-analysis
– volume: 113
  start-page: 600
  year: 2016
  ident: ref2
  article-title: Prevalence and prevention of cardiovascular disease and diabetes mellitus
  publication-title: Pharmacol Res
– volume: 135
  start-page: 1301
  year: 1992
  ident: ref68
  article-title: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis
  publication-title: Am J Epidemiol
– volume: 15
  start-page: 230
  year: 2018
  ident: ref1
  article-title: Epidemiology of cardiovascular disease in young individuals
  publication-title: Nat Rev Cardiol
– volume: 173
  start-page: 1318
  year: 2013
  ident: ref32
  article-title: Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality
  publication-title: JAMA Intern Med
– volume: 327
  start-page: 557
  year: 2003
  ident: ref65
  article-title: Measuring inconsistency in meta-analyses
  publication-title: BMJ
– volume: 122
  start-page: 1260
  year: 2020
  ident: ref89
  article-title: Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials
  publication-title: Br J Cancer
– volume: 102
  start-page: 1621
  year: 2002
  ident: ref93
  article-title: Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids
  publication-title: J Am Diet Assoc
– volume: 3
  start-page: 406
  year: 2010
  ident: ref31
  article-title: Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study
  publication-title: Circ Cardiovasc Qual Outcomes
– volume: 123
  start-page: 51
  year: 2017
  ident: ref4
  article-title: Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease
  publication-title: Fitoterapia
– volume: 121
  start-page: 2244
  year: 2015
  ident: ref23
  article-title: Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: A population-based follow-up study on Long Island, New York
  publication-title: Cancer
– volume: 165
  start-page: 193
  year: 2005
  ident: ref25
  article-title: Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids
  publication-title: Arch Intern Med
– volume: 134
  start-page: 919
  year: 2004
  ident: ref57
  article-title: Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis
  publication-title: J Nutr
– volume: 11
  start-page: 250
  year: 2017
  ident: ref21
  article-title: Red blood cell polyunsaturated fatty acids and mortality in the Women’s Health Initiative Memory Study
  publication-title: J Clin Lipidol
– volume: 146
  start-page: 44
  year: 2020
  ident: ref53
  article-title: Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition
  publication-title: Int J Cancer
– volume: 80
  start-page: 950
  year: 2020
  ident: ref67
  article-title: Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer
  publication-title: Prostate
– volume: 366
  start-page: l4009
  year: 2019
  ident: ref22
  article-title: Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies
  publication-title: BMJ
– volume: 12
  start-page: 2329
  year: 2021
  ident: ref54
  article-title: Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies
  publication-title: Nat Commun
– volume: 9
  start-page: 345
  year: 2018
  ident: ref10
  article-title: Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits
  publication-title: Annu Rev Food Sci Technol
– volume: 10
  year: 2021
  ident: ref71
  article-title: Plasma Omega-3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN-TIMI 36
  publication-title: J Am Heart Assoc
– volume: 145
  start-page: 876
  year: 1997
  ident: ref30
  article-title: Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
  publication-title: Am J Epidemiol
– volume: 16
  start-page: 32
  year: 2017
  ident: ref6
  article-title: Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review
  publication-title: Integr Cancer Ther
– volume: 30
  start-page: 1119
  year: 2001
  ident: ref76
  article-title: Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men
  publication-title: Int J Epidemiol
– volume: 13
  start-page: 196
  year: 2014
  ident: ref12
  article-title: The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population
  publication-title: Lipids Health Dis
– volume: 112
  start-page: 1206
  year: 2014
  ident: ref20
  article-title: Plasma phospholipid and dietary α-linolenic acid, mortality, CHD and stroke: the Cardiovascular Health Study
  publication-title: Br J Nutr
– volume: 39
  start-page: 3677
  year: 2020
  ident: ref82
  article-title: Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective studies with 1,164,029 participants
  publication-title: Clin Nutr
– ident: 2023030804355048000_375.oct13_9.n2213.36
  doi: 10.1016/j.clnu.2018.02.019
– ident: 2023030804355048000_375.oct13_9.n2213.66
  doi: 10.1186/1471-2288-14-70
– ident: 2023030804355048000_375.oct13_9.n2213.3
  doi: 10.1016/S0140-6736(14)60648-6
– ident: 2023030804355048000_375.oct13_9.n2213.79
  doi: 10.1093/ajcn/80.1.204
– ident: 2023030804355048000_375.oct13_9.n2213.39
  doi: 10.1016/j.nutres.2016.09.006
– ident: 2023030804355048000_375.oct13_9.n2213.5
  doi: 10.1080/17512433.2017.1333902
– ident: 2023030804355048000_375.oct13_9.n2213.87
  doi: 10.1055/s-0038-1642387
– ident: 2023030804355048000_375.oct13_9.n2213.69
  doi: 10.1177/1536867X0600600103
– ident: 2023030804355048000_375.oct13_9.n2213.75
  doi: 10.3181/00379727-200-43413
– ident: 2023030804355048000_375.oct13_9.n2213.31
  doi: 10.1161/CIRCOUTCOMES.109.896159
– ident: 2023030804355048000_375.oct13_9.n2213.70
  doi: 10.1093/ndt/gfs132
– ident: 2023030804355048000_375.oct13_9.n2213.35
  doi: 10.1093/ajcn/88.1.203
– ident: 2023030804355048000_375.oct13_9.n2213.49
  doi: 10.1016/j.atherosclerosis.2016.06.049
– ident: 2023030804355048000_375.oct13_9.n2213.60
  doi: 10.1001/jama.279.18.1477
– ident: 2023030804355048000_375.oct13_9.n2213.55
  doi: 10.1017/S0007114517003294
– ident: 2023030804355048000_375.oct13_9.n2213.7
  doi: 10.3945/an.114.006940
– ident: 2023030804355048000_375.oct13_9.n2213.28
  doi: 10.1161/CIRCULATIONAHA.115.015607
– ident: 2023030804355048000_375.oct13_9.n2213.71
  doi: 10.1161/JAHA.120.017401
– ident: 2023030804355048000_375.oct13_9.n2213.54
  doi: 10.1038/s41467-021-22370-2
– ident: 2023030804355048000_375.oct13_9.n2213.83
  doi: 10.1093/ajcn/nqz349
– ident: 2023030804355048000_375.oct13_9.n2213.25
  doi: 10.1001/archinte.165.2.193
– ident: 2023030804355048000_375.oct13_9.n2213.40
  doi: 10.3945/ajcn.110.009977
– ident: 2023030804355048000_375.oct13_9.n2213.58
  doi: 10.1136/bmj.g7647
– ident: 2023030804355048000_375.oct13_9.n2213.89
  doi: 10.1038/s41416-020-0761-6
– ident: 2023030804355048000_375.oct13_9.n2213.77
  doi: 10.1093/ajcn/69.5.890
– ident: 2023030804355048000_375.oct13_9.n2213.10
  doi: 10.1146/annurev-food-111317-095850
– ident: 2023030804355048000_375.oct13_9.n2213.37
  doi: 10.1161/CIRCRESAHA.118.314038
– ident: 2023030804355048000_375.oct13_9.n2213.8
  doi: 10.1194/jlr.R055095
– ident: 2023030804355048000_375.oct13_9.n2213.14
  doi: 10.3945/ajcn.115.127019
– ident: 2023030804355048000_375.oct13_9.n2213.21
  doi: 10.1016/j.jacl.2016.12.013
– ident: 2023030804355048000_375.oct13_9.n2213.73
  doi: 10.1158/1055-9965.EPI-18-0940
– ident: 2023030804355048000_375.oct13_9.n2213.23
  doi: 10.1002/cncr.29329
– ident: 2023030804355048000_375.oct13_9.n2213.26
  doi: 10.1016/j.clnu.2019.02.030
– ident: 2023030804355048000_375.oct13_9.n2213.22
  doi: 10.1136/bmj.l4009
– ident: 2023030804355048000_375.oct13_9.n2213.65
  doi: 10.1136/bmj.327.7414.557
– ident: 2023030804355048000_375.oct13_9.n2213.29
  doi: 10.1093/ajcn/74.4.457
– ident: 2023030804355048000_375.oct13_9.n2213.63
  doi: 10.1016/S0140-6736(10)60484-9
– ident: 2023030804355048000_375.oct13_9.n2213.81
  doi: 10.3945/ajcn.112.044040
– ident: 2023030804355048000_375.oct13_9.n2213.41
  doi: 10.1001/jamainternmed.2016.2925
– ident: 2023030804355048000_375.oct13_9.n2213.16
  doi: 10.1159/000419291
– ident: 2023030804355048000_375.oct13_9.n2213.44
  doi: 10.1136/bmj.313.7049.84
– ident: 2023030804355048000_375.oct13_9.n2213.4
  doi: 10.1016/j.fitote.2017.09.015
– ident: 2023030804355048000_375.oct13_9.n2213.32
  doi: 10.1001/jamainternmed.2013.6536
– ident: 2023030804355048000_375.oct13_9.n2213.82
  doi: 10.1016/j.clnu.2020.03.028
– ident: 2023030804355048000_375.oct13_9.n2213.56
  doi: 10.3945/ajcn.2009.26736E
– volume: 77
  start-page: 85
  year: 2009
  ident: 2023030804355048000_375.oct13_9.n2213.62
  article-title: Fixed-effect versus random-effects models
  publication-title: Introduction to Meta-analysis
– ident: 2023030804355048000_375.oct13_9.n2213.53
  doi: 10.1002/ijc.32233
– ident: 2023030804355048000_375.oct13_9.n2213.48
  doi: 10.1016/j.jacl.2018.02.010
– ident: 2023030804355048000_375.oct13_9.n2213.18
  doi: 10.1093/ajcn/78.1.65
– ident: 2023030804355048000_375.oct13_9.n2213.72
  doi: 10.1016/j.metabol.2008.11.013
– ident: 2023030804355048000_375.oct13_9.n2213.92
  doi: 10.1186/1741-7015-11-164
– ident: 2023030804355048000_375.oct13_9.n2213.34
  doi: 10.1001/jamainternmed.2016.2417
– ident: 2023030804355048000_375.oct13_9.n2213.1
  doi: 10.1038/nrcardio.2017.154
– ident: 2023030804355048000_375.oct13_9.n2213.27
  doi: 10.1093/ajcn/88.3.722
– ident: 2023030804355048000_375.oct13_9.n2213.46
  doi: 10.1016/j.amepre.2016.07.020
– ident: 2023030804355048000_375.oct13_9.n2213.86
  doi: 10.1016/j.lfs.2018.04.049
– ident: 2023030804355048000_375.oct13_9.n2213.64
  doi: 10.1002/ijc.29210
– ident: 2023030804355048000_375.oct13_9.n2213.43
  doi: 10.1161/CIRCULATIONAHA.105.572008
– ident: 2023030804355048000_375.oct13_9.n2213.78
  doi: 10.1002/ijc.31247
– ident: 2023030804355048000_375.oct13_9.n2213.17
  doi: 10.1093/aje/kwr520
– ident: 2023030804355048000_375.oct13_9.n2213.67
  doi: 10.1002/pros.24027
– ident: 2023030804355048000_375.oct13_9.n2213.68
  doi: doi:10.1093/oxfordjournals.aje.a116237
– ident: 2023030804355048000_375.oct13_9.n2213.74
  doi: 10.1093/aje/kwh307
– ident: 2023030804355048000_375.oct13_9.n2213.9
  doi: 10.3390/nu11122974
– ident: 2023030804355048000_375.oct13_9.n2213.52
  doi: 10.1016/j.ijcard.2012.09.076
– ident: 2023030804355048000_375.oct13_9.n2213.88
  doi: 10.1038/sj.ejcn.1602408
– ident: 2023030804355048000_375.oct13_9.n2213.19
  doi: 10.1097/00001648-200007000-00013
– ident: 2023030804355048000_375.oct13_9.n2213.38
  doi: 10.1161/JAHA.115.002543
– ident: 2023030804355048000_375.oct13_9.n2213.12
  doi: 10.1186/1476-511X-13-196
– ident: 2023030804355048000_375.oct13_9.n2213.76
  doi: 10.1093/ije/30.5.1119
– ident: 2023030804355048000_375.oct13_9.n2213.11
  doi: 10.1080/10408398.2013.828678
– ident: 2023030804355048000_375.oct13_9.n2213.2
  doi: 10.1016/j.phrs.2016.09.040
– ident: 2023030804355048000_375.oct13_9.n2213.59
  doi: 10.1186/s13643-018-0915-2
– ident: 2023030804355048000_375.oct13_9.n2213.80
  doi: 10.1093/ajcn/77.2.319
– ident: 2023030804355048000_375.oct13_9.n2213.91
  doi: 10.1186/s12916-016-0730-3
– ident: 2023030804355048000_375.oct13_9.n2213.61
  doi: 10.1016/j.cct.2015.09.002
– ident: 2023030804355048000_375.oct13_9.n2213.47
  doi: 10.1001/jamacardio.2016.2259
– ident: 2023030804355048000_375.oct13_9.n2213.50
  doi: 10.1016/j.nut.2019.110610
– ident: 2023030804355048000_375.oct13_9.n2213.15
  doi: 10.1371/journal.pone.0059408
– ident: 2023030804355048000_375.oct13_9.n2213.30
  doi: 10.1093/oxfordjournals.aje.a009047
– ident: 2023030804355048000_375.oct13_9.n2213.45
  doi: 10.1158/1055-9965.EPI-12-1196-T
– ident: 2023030804355048000_375.oct13_9.n2213.57
  doi: 10.1093/jn/134.4.919
– ident: 2023030804355048000_375.oct13_9.n2213.33
  doi: 10.1093/oxfordjournals.aje.a009710
– ident: 2023030804355048000_375.oct13_9.n2213.93
  doi: 10.1016/S0002-8223(02)90346-9
– ident: 2023030804355048000_375.oct13_9.n2213.51
  doi: 10.1016/j.jacc.2020.08.073
– ident: 2023030804355048000_375.oct13_9.n2213.85
  doi: 10.1002/14651858.CD003177.pub3
– volume: 11
  start-page: 24
  year: 2005
  ident: 2023030804355048000_375.oct13_9.n2213.13
  article-title: Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence
  publication-title: Altern Ther Health Med
– ident: 2023030804355048000_375.oct13_9.n2213.42
  doi: 10.1017/S000711451400138X
– ident: 2023030804355048000_375.oct13_9.n2213.90
  doi: 10.1097/MCO.0000000000000439
– ident: 2023030804355048000_375.oct13_9.n2213.20
  doi: 10.1017/S0007114514001925
– ident: 2023030804355048000_375.oct13_9.n2213.24
  doi: 10.1177/2047487313517576
– ident: 2023030804355048000_375.oct13_9.n2213.84
  doi: 10.3181/0711-MR-311
– ident: 2023030804355048000_375.oct13_9.n2213.6
  doi: 10.1177/1534735416656052
SSID ssj0002378965
Score 2.6620867
SecondaryResourceType review_article
Snippet AbstractObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes,...
To examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular...
ObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes,...
SourceID pubmedcentral
proquest
pubmed
crossref
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage n2213
SubjectTerms alpha-Linolenic Acid - blood
alpha-Linolenic Acid - metabolism
Bias
Biomarkers
Blood levels
Cancer
Cardiovascular disease
Cardiovascular diseases
Cardiovascular Diseases - metabolism
Cardiovascular Diseases - mortality
Chronic illnesses
Cohort analysis
Confidence intervals
Coronary artery disease
Dietary intake
Eating - physiology
Estimates
Fatty acids
Heart diseases
Humans
Linolenic acid
Meta-analysis
Mortality
Neoplasms - metabolism
Neoplasms - mortality
Protective Factors
Reviews
Risk Assessment
Statistical analysis
Systematic review
Variables
Title Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies
URI https://bmj.com/content/375/bmj.n2213.full
https://www.ncbi.nlm.nih.gov/pubmed/34645650
https://www.proquest.com/docview/2593890978
https://www.proquest.com/docview/2582108661
https://pubmed.ncbi.nlm.nih.gov/PMC8513503
Volume 375
WOSCitedRecordID wos000708090000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250928
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: M7P
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250928
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: 7X7
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250928
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: 7RV
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250928
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: BENPR
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250928
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: M2O
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 1756-1833
  dateEnd: 20250928
  omitProxy: false
  ssIdentifier: ssj0002378965
  issn: 1756-1833
  databaseCode: M2P
  dateStart: 19940108
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RFiEuvB-BsjKIA4embewktrkgHq24dFlVgPa2cmxHBLpJSbJI_DF-Hx7Hu9uFigsX5-FPshWP4xnP5xmA55QZprgzcpJc5HGamDKWzgiLqeEsU7nKEl74ZBN8PBbTqZyEDbcu0CqX_0T_ozaNxj3yA6emu7UVTx28Ov8eY9Yo9K6GFBpbsINREpin7k1WeyyUcSHzLAQUSlh-UMy_7teU-mQG7n5zMfpLw_yTKHlh5Tm--b99vgU3gs5JXg9Cchuu2PoOXDsJXvW78OtdZXvV_iRV3atvlqjaEDyWj8ydtiNNSfyJXOI0UvTiV5ooXRkPQ2b6ADgjWi06u-cuFxmuex6mUbZaMve6vtP7X5J1BGkynJ7xONN0Nm4H2q4lc9erWIWoKdgKZvNte9IN3Md78On46OPb93HI5xAXGeN9rBLr5riWiU55ycsy41QUwt2UmgktD7WUhrEktc4G4kZl2ukXyqRaqNQkWZmw-7BdN7V9CESwojDO2JNM6zQzUlDtBMvgpy6KXNoIRm54Z2E-djNv6rB8hi_9-EfwYjnyMx2ioWNSjrPLoM9W0PMhBMhloN2lCKxbXY9_BE9X1W7-olNG1bZZIEZQzHaVJxE8GKRt1QpDt7NToSPgG3K4AmBs8M2auvriY4Q7RZplh-zRv7v1GK5T5OggQ4ftwnbfLuwTuKp_9FXXjmCLn37Gcsp9KUaw8-ZoPDl1Tyf0gy8nIz_lfgNKXDV3
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VgigXvgsLpRgEEoeG1nYSJ0gIIUrVqu0KoYJ6WxzbEYFutiRZUP8UR34fM052twsVtx44bbR5iqNkZjwvfp4BeCKklVohyeFxEgcht3mQIgkLhFUy0rGOuMp8swnV7yeHh-m7Bfg52QtDsspJTPSB2o4MfSNfxzQd51badfDq-FtAXaNodXXSQqM1i1138gMpW_1yZxPf71Mhtt4evNkOuq4CQRZJ1QSaO7Q0k3ITqlzleaREkiV4kBuZmHTDpKmVkocOM3FldWRwltM2NIkOLY9yLvG6F-AixnFOEjL1_uP0m46QKknjqCtgxGW8ng2_PC-F8M0T8Hh-8vsro_1TmHlqptu69r89o-twtcup2evWCW7AgitvwuX9TjVwC35tFq7R1QkrykZ_dUyXllHZAVImVTUb5czvOGaYcZNKoTBMm8J6GCnvW8ARM3pcuzX8Oa3gXfMwQ75TsaHnMshrXrBZhWzW7g7yODuqXVC1smTHhnhXge6qwtAo1K24aljdajtvw4dzeWrLsFiOSncXWCKzzCKZTaUxYWTTRBh0HEuvNsvi1PVgFc1p0MWbeuCpnIwH9Ke3tx48m1jawHTV3qnpyNFZ0MdT6HFb4uQs0MrE5GajzuytB4-mpzE-0aKTLt1oTJhEUDevmPfgTmvd01EkLasjReiBmrP7KYBqn8-fKYvPvgY6EgUZbch7_76th7C0fbC_N9jb6e_ehyuC9EikRpIrsNhUY_cALpnvTVFXq96RGXw6b6_4DSgujKQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VgioufH8slGIQSBwatrGTOEFCCLGsqAqrPYDUW-rYjprSzZYkC-of48CvY8bJ7nah4tYDp0TJUxwlM_aM_fwG4BkXRiiJSY4fxZEX-Cb3EkzCPG6kCFWkQl9mrtiEHI3i_f1kvAa_5nthiFY57xNdR22mmubI-xim49hKuw76eUeLGA-Gb06-eVRBilZa5-U0WhPZs6c_MH2rX-8O8F8_53z4_vO7D15XYcDLQiEbT_kWrU4nvg5kLvM8lDzOYjzJtYh1sqOTxAjhBxajcmlUqHHEUybQsQqMH-a-wOdegsuSRMsdbXC8mN_hQsZJFHZiRr6I-tnk6GXJuSukgOerA-Ff0e2fJM0zo97w-v_8vW7AtS7WZm9b57gJa7a8BRufOjbBbfg5KGyjqlNWlI36apkqDSM5AmIsVTWb5sztRGYYiRN7odBM6cI4GDHyW8Ax02pW2208nGX2bjuYJp-q2MTlOJjvvGJL5WzW7hpyODOtrVe1dGXLJvhWnurUYqgVqmJcNaxuOZ934MuFfLW7sF5OS3sfWCyyzGCSmwitg9AkMdfoUIZ-c5ZFie3BFppW2vVDdepSPBGldNHZXg9ezK0u1Z0KPBUjOT4P-nQBPWmlT84Dbc7Nb9nq0vZ68GRxG_stWoxSpZ3OCBNzqvIV-T2411r6ohVBy-2YOvRArvjAAkCa6Kt3yuLQaaNjAiHCHfHg36_1GDbQGdKPu6O9h3CVE00JwxEebcJ6U83sI7iivzdFXW05n2ZwcNFO8RsC45VK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dietary+intake+and+biomarkers+of+alpha+linolenic+acid+and+risk+of+all+cause%2C+cardiovascular%2C+and+cancer+mortality%3A+systematic+review+and+dose-response+meta-analysis+of+cohort+studies&rft.jtitle=BMJ.+British+medical+journal+%28Clinical+research+ed.%29&rft.au=Naghshi%2C+Sina&rft.au=Aune%2C+Dagfinn&rft.au=Beyene%2C+Joseph&rft.au=Mobarak%2C+Sara&rft.date=2021-10-13&rft.pub=BMJ+Publishing+Group+Ltd&rft.issn=0959-8138&rft.eissn=1756-1833&rft.volume=375&rft_id=info:doi/10.1136%2Fbmj.n2213&rft_id=info%3Apmid%2F34645650&rft.externalDocID=PMC8513503
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-1833&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-1833&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-1833&client=summon